Structural criteria for regulation of membrane fusion and virion incorporation by the murine leukemia virus TM cytoplasmic domain

Virology

Volumn 312, Issue 2, 2003, Pages 295-305

  Taylor, Gwen M ^a   Sanders, David Avram ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Cytoplasmic domain; Envelope; Membrane fusion; Murine leukemia virus; Protease; Retrovirus; Transmembrane

Indexed keywords

PROTEIN SUBUNIT; VIRUS ENVELOPE PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CYTOPLASM VESICLE; ENZYME MECHANISM; MEMBRANE FUSION; MOLONEY LEUKEMIA ONCOVIRUS; MURINE LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; VIRION; VIRUS ENVELOPE; VIRUS MORPHOLOGY; VIRUS PARTICLE;

MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; MURINE LEUKEMIA VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0043064053     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00297-6     Document Type: Article

References (69)

1. Aguilar H.C., Anderson W.F., Cannon P.M. Cytoplasmic tail of Moloney murine leukemia virus envelope protein influences the conformation of the extracellular domain implications for mechanism of action of the R Peptide . J. Virol. 77:2003;1281-1291.
2. Bagai S., Lamb R.A. Truncation of the COOH-terminal region of the paramyxovirus SV5 fusion protein leads to hemifusion but not complete fusion. J. Cell Biol. 135:1996;73-84.
3. 2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events. EMBO J. 12:1993;5105-5112.
4. Bobkova M., Stitz J., Engelstadter M., Cichutek K., Buchholz C.J. Identification of R-peptides in envelope proteins of C-type retroviruses. J. Gen. Virol. 83:2002;2241-2246.
5. Brody B.A., Rhee S.S., Hunter E. Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity. J. Virol. 68:1994;4620-4627.
6. Cathomen T., Naim H.Y., Cattaneo R. Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J. Virol. 72:1998;1224-1234.
7. Christodoulopoulos I., Cannon P.M. Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors. J. Virol. 75:2001;4129-4138.
8. Copeland T.D., Gerard G.F., Hixson C.W., Oroszlan S. Amino- and carboxyl-terminal sequence of Moloney murine leukemia virus reverse transcriptase. Virology. 143:1985;676-679.
9. Crawford S., Goff S.P. A deletion mutation in the 5′ part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins. J. Virol. 53:1985;899-907.
10. Egan M.A., Carruth L.M., Rowell J.F., Yu X., Siliciano R.F. Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein. J. Virol. 70:1996;6547-6556.
11. Foster T.P., Melancon J.M., Kousoulas K.G. An α-helical domain within the carboxyl terminus of herpes simplex virus type 1 (HSV-1) glycoprotein B (gB) is associated with cell fusion and resistance to heparin inhibition of cell fusion. Virology. 287:2001;18-29.
12. Gage P.J., Levine M., Glorioso J.C. Syncytium-inducing mutations localize to two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B. J. Virol. 67:1993;2191-2201.
13. Gonzalez L. Jr., Woolfson D.N., Alber T. Buried polar residues and structural specificity in the GCN4 leucine zipper. Nat. Struct. Biol. 3:1996;1011-1018.
14. Grange M.P., Blot V., Delamarre L., Bouchaert I., Rocca A., Dautry-Varsat A., Dokhelar M.C. Identification of two intracellular mechanisms leading to reduced expression of oncoretrovirus envelope glycoproteins at the cell surface. J. Virol. 74:2000;11734-11743.
15. Granowitz C., Berkowitz R.D., Goff S.P. Mutations affecting the cytoplasmic domain of the Moloney murine leukemia virus envelope protein rapid reversion during replication . Virus. Res. 41:1996;25-42.
16. Green N., Shinnick T.M., Witte O., Ponticelli A., Sutcliffe J.G., Lerner R.A. Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc. Natl. Acad. Sci. USA. 78:1981;6023-6027.
17. Harbury P.B., Zhang T., Kim P.S., Alber T. A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. Science. 262:1993;1401-1407.
18. Henderson L.E., Sowder R., Copeland T.D., Smythers G., Oroszlan S. Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products. J. Virol. 52:1984;492-500.
19. Januszeski M.M., Cannon P.M., Chen D., Rozenberg Y., Anderson W.F. Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J. Virol. 71:1997;3613-3619.
20. Jin H., Leser G.P., Zhang J., Lamb R.A. Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J. 16:1997;1236-1247.
21. Jones J.S., Risser R. Cell fusion induced by the murine leukemia virus envelope glycoprotein. J. Virol. 67:1993;67-74.
22. Kamps C.A., Lin Y.C., Wong P.K. Oligomerization and transport of the envelope protein of Moloney murine leukemia virus-TB and of ts1, a neurovirulent temperature-sensitive mutant of MoMuLV-TB. Virology. 184:1991;687-694.
23. Katen L.J., Januszeski M.M., Anderson W.F., Hasenkrug K.J., Evans L.H. Infectious entry by amphotropic as well as ecotropic murine leukemia viruses occurs through an endocytic pathway. J. Virol. 75:2001;5018-5026.
24. Katoh I., Yoshinaka Y., Rein A., Shibuya M., Odaka T., Oroszlan S. Murine leukemia virus maturation protease region required for conversion from "immature" to "mature" core form and for virus infectivity . Virology. 145:1985;280-292.
25. Kozerski C., Ponimaskin E., Schroth-Diez B., Schmidt M.F., Hermann A. Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore. J. Virol. 74:2000;7529-7537.
26. LaBranche C.C., Sauter M.M., Haggarty B.S., Vance P.J., Romano J., Hart T.K., Bugelski P.J., Marsh M., Hoxie J.A. A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells. J. Virol. 69:1995;5217-5227.
27. Lee S., Zhao Y., Anderson W.F. Receptor-mediated Moloney murine leukemia virus entry can occur independently of the clathrin-coated-pit-mediated endocytic pathway. J. Virol. 73:1999;5994-6005.
28. Li M., Yang C., Compans R.W. Mutations in the cytoplasmic tail of murine leukemia virus envelope protein suppress fusion inhibition by R peptide. J. Virol. 75:2001;2337-2344.
29. Li Z., Pinter A., Kayman S.C. The critical N-linked glycan of murine leukemia virus envelope protein promotes both folding of the C-terminal domains of the precursor polyprotein and stability of the postcleavage envelope complex. J. Virol. 71:1997;7012-7019.
30. Lindemann D., Bock M., Schweizer M., Rethwilm A. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J. Virol. 71:1997;4815-4820.
31. Lodge R., Delamarre L., Lalonde J.-P., Alvarado J., Sanders D.A., Dokhelar M.-C., Cohen E.A., Lemay G. Two distinct oncornaviruses harbor an intracytoplasmic tyrosine-based basolateral targeting signal in their viral envelope glycoprotein. J. Virol. 71:1997;5696-5702.
32. Lodge R., Subbramanian R.A., Forget J., Lemay G., Cohen E.A. MuLV-based vectors pseudotyped with truncated HIV glycoproteins mediate specific gene transfer in CD4+ peripheral blood lymphocytes. Gene. Ther. 5:1998;655-664.
33. McClure M.O., Sommerfelt M.A., Marsh M., Weiss R.A. The pH independence of mammalian retrovirus infection. J. Gen. Virol. 71:1990;767-773.
34. Melikyan G.B., Markosyan R.M., Brener S.A., Rozenberg Y., Cohen F.S. Role of the cytoplasmic tail of ecotropic moloney murine leukemia virus Env protein in fusion pore formation. J. Virol. 74:2000;447-455.
35. Mulligan M.J., Yamshchikov G.V., Ritter G. Jr., Gao F., Jin M.J., Nail C.D., Spies C.P., Hahn B.H., Compans R.W. Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types. J. Virol. 66:1992;3971-3975.
36. Nussbaum O., Roop A., Anderson W.F. Sequences determining the pH dependence of viral entry are distinct from the host range-determining region of the murine ecotropic and amphotropic retrovirus envelope proteins. J. Virol. 67:1993;7402-7405.
37. Opstelten D.J., Wallin M., Garoff H. Moloney murine leukemia virus envelope protein subunits, gp70 and Pr15E, form a stable disulfide-linked complex. J. Virol. 72:1998;6537-6545.
38. Owen K.E., Kuhn R.J. Alphavirus budding is dependent on the interaction between the nucleocapsid and hydrophobic amino acids on the cytoplasmic domain of the E2 envelope glycoprotein. Virology. 230:1997;187-196.
39. Owens R.J., Rose J.K. Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus. J. Virol. 67:1993;360-365.
40. Palmarini M., Maeda N., Murgia C., De-Fraja C., Hofacre A., Fan H. A phosphatidylinositol 3-kinase docking site in the cytoplasmic tail of the Jaagsiekte sheep retrovirus transmembrane protein is essential for envelope-induced transformation of NIH 3T3 cells. J. Virol. 75:2001;11002-11009.
41. Pickl W.F., Pimentel-Muinos F.X., Seed B. Lipid rafts and pseudotyping. J. Virol. 75:2001;7175-7183.
42. Pinter A., Honnen W.J. Topography of murine leukemia virus envelope proteins characterization of transmembrane components . J. Virol. 46:1983;1056-1060.
43. Pinter A., Kopelman R., Li Z., Kayman S.C., Sanders D.A. Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active site sequence of thiol-disulfide exchange enzymes. J. Virol. 71:1997;8073-8077.
44. Pinter A., Lieman-Hurwitz J., Fleissner E. The nature of the association between the murine leukemia virus envelope proteins. Virology. 91:1978;345-351.
45. Qiao H., Pelletier S.L., Hoffman L., Hacker J., Armstrong R.T., White J.M. Specific single or double proline substitutions in the "spring-loaded" coiled-coil region of the influenza hemagglutinin impair or abolish membrane fusion activity. J. Cell Biol. 141:1998;1335-1347.
46. Ragheb J.A., Anderson W.F. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion implications for the role of the R peptide and p12E TM in viral entry . J. Virol. 68:1994;3220-3231.
47. Raviprakash K., Rasile L., Ghosh K., Ghosh H.P. Shortened cytoplasmic domain affects intracellular transport but not nuclear localization of a viral glycoprotein. J. Biol. Chem. 265:1990;1777-1782.
48. Rein A., Mirro J., Haynes J.G., Ernst S.M., Nagashima K. Function of the cytoplasmic domain of a retroviral transmembrane protein p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein . J. Virol. 68:1994;1773-1781.
49. Ritter G.D. Jr., Mulligan M.J., Lydy S.L., Compans R.W. Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain. Virology. 197:1993;255-264.
50. Sanders D.A. Sulfhydryl involvement in fusion mechanisms. Hilderson H., Fuller S. Fusion of Biological Membranes and Related Problems. 2000;483-514 Kluwer Academic/Plenum, New York.
51. Sauter M.M., Pelchen-Matthews A., Bron R., Marsh M., LaBranche C.C., Vance P.J., Romano J., Haggarty B.S., Hart T.K., Lee W.M., Hoxie J.A. An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface. J. Cell Biol. 132:1996;795-811.
52. Schnierle B.S., Stitz J., Bosch V., Nocken F., Merget-Millitzer H., Engelstadter M., Kurth R., Groner B., Cichutek K. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc. Natl. Acad. Sci. USA. 94:1997;8640-8645.
53. Schultz A., Rein A. Maturation of murine leukemia virus env proteins in the absence of other viral proteins. Virology. 145:1985;335-339.
54. Sergel T., Morrison T.G. Mutations in the cytoplasmic domain of the fusion glycoprotein of Newcastle disease virus depress syncytia formation. Virology. 210:1995;264-272.
55. Sharkey C.M., North C.L., Kuhn R.J., Sanders D.A. Ross River virus glycoprotein-pseudotyped retroviruses and stable cell lines for their production. J. Virol. 75:2001;2653-2659.
56. Shinnick T.M., Lerner R.A., Sutcliffe J.G. Nucleotide sequence of Moloney murine leukaemia virus. Nature. 293:1981;543-548.
57. Sutcliffe J.G., Shinnick T.M., Green N., Liu F.T., Niman H.L., Lerner R.A. Chemical synthesis of a polypeptide predicted from nucleotide sequence allows detection of a new retroviral gene product. Nature. 287:1980;801-805.
58. Taylor G.M., Gao Y., Sanders D.A. Fv-4 identification of the defect in env and the mechanism of resistance to ecotropic murine leukemia virus . J. Virol. 75:2001;11244-11248.
59. Taylor G.M., Sanders D.A. The role of the membrane-spanning domain sequence in glycoprotein-mediated membrane fusion. Mol. Biol. Cell. 10:1999;2803-2815.
60. Vincent M.J., Melsen L.R., Martin A.S., Compans R.W. Intracellular interaction of simian immunodeficiency virus Gag and Env proteins. J. Virol. 73:1999;8138-8144.
61. Witte O.N., Tsukamoto A.A., Weissman I.L. Cellular maturation of oncornavirus glycoproteins topological arrangement of precursor and product forms in cellular membranes . Virology. 76:1977;539-553.
62. Woolfson D.N., Alber T. Predicting oligomerization states of coiled coils. Protein Sci. 4:1995;1596-1607.
63. Yang C., Compans R.W. Analysis of the murine leukemia virus R peptide delineation of the molecular determinants which are important for its fusion inhibition activity . J. Virol. 71:1997;8490-8496.
64. Yoshinaka Y., Katoh I., Copeland T.D., Oroszlan S. Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon. Proc. Natl. Acad. Sci. USA. 82:1985;1618-1622.
65. Yu H., Empig C., Xia J., Anderson W.F. Quantitation of MoMuLV envelope protein on the cell surface. Virology. 243:1998;415-422.
66. Zhang J., Pekosz A., Lamb R.A. Influenza virus assembly and lipid raft microdomains a role for the cytoplasmic tails of the spike glycoproteins . J. Virol. 74:2000;4634-4644.
67. Zhao H., Lindqvist B., Garoff H., von Bonsdorff C.H., Liljestrom P. A tyrosine-based motif in the cytoplasmic domain of the alphavirus envelope protein is essential for budding. EMBO J. 13:1994;4204-4211.
68. Zhu N.L., Cannon P.M., Chen D., Anderson W.F. Mutational analysis of the fusion peptide of Moloney murine leukemia virus transmembrane protein p15E. J. Virol. 72:1998;1632-1639.
69. Zitzewitz J.A., Bilsel O., Luo J., Jones B.E., Matthews C.R. Probing the folding mechanism of a leucine zipper peptide by stopped-flow circular dichroism spectroscopy. Biochemistry. 34:1995;12812-12819.